NL8101899A - Farmaceutisch preparaat voor orale toediening met daarin cytidinedifosfocholine. - Google Patents

Farmaceutisch preparaat voor orale toediening met daarin cytidinedifosfocholine. Download PDF

Info

Publication number
NL8101899A
NL8101899A NL8101899A NL8101899A NL8101899A NL 8101899 A NL8101899 A NL 8101899A NL 8101899 A NL8101899 A NL 8101899A NL 8101899 A NL8101899 A NL 8101899A NL 8101899 A NL8101899 A NL 8101899A
Authority
NL
Netherlands
Prior art keywords
choline
cdp
pharmaceutical preparation
oral administration
phospholipids
Prior art date
Application number
NL8101899A
Other languages
English (en)
Dutch (nl)
Original Assignee
Made Italiana Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Made Italiana Srl filed Critical Made Italiana Srl
Publication of NL8101899A publication Critical patent/NL8101899A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8101899A 1980-04-18 1981-04-16 Farmaceutisch preparaat voor orale toediening met daarin cytidinedifosfocholine. NL8101899A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT4845480 1980-04-18
IT8048454A IT1207106B (it) 1980-04-18 1980-04-18 Preparazione farmaceutica contenente citidin disfofocolina assorbibile per via orale

Publications (1)

Publication Number Publication Date
NL8101899A true NL8101899A (nl) 1981-11-16

Family

ID=11266633

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8101899A NL8101899A (nl) 1980-04-18 1981-04-16 Farmaceutisch preparaat voor orale toediening met daarin cytidinedifosfocholine.

Country Status (15)

Country Link
US (1) US4386077A (es)
AT (1) AT376366B (es)
AU (1) AU544469B2 (es)
BE (1) BE890796A (es)
CH (1) CH652026A5 (es)
DE (1) DE3115080C2 (es)
DK (1) DK173081A (es)
ES (1) ES8207184A1 (es)
FR (1) FR2480603B1 (es)
GB (1) GB2074445B (es)
IN (1) IN156105B (es)
IT (1) IT1207106B (es)
NL (1) NL8101899A (es)
SE (1) SE447449B (es)
ZA (1) ZA812600B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569929A (en) * 1980-02-29 1986-02-11 Massachusetts Institute Of Technology Cytidyl diphosphocholine-drug composition
EP0114577A1 (en) * 1983-01-21 1984-08-01 MAGIS FARMACEUTICI S.p.A. New pharmaceutical composition
IT1201474B (it) * 1985-10-01 1989-02-02 Vincenzo Zappia Derivati macromolecolarizzati di cdp-colina,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
US5482706A (en) * 1992-04-17 1996-01-09 Takeda Chemical Industries, Ltd. Transmucosal therapeutic composition
AU2005201251B2 (en) * 1995-03-06 2006-04-27 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
US5872108A (en) * 1995-03-06 1999-02-16 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
PL185124B1 (pl) * 1995-03-06 2003-02-28 Interneuron Pharmaceuticals Zastosowanie cytykoliny oraz jej kompozycja do wytwarzania leku przeznaczonego do ochrony tkanki mózgowej
AU1640400A (en) * 1995-03-06 2000-04-20 Interneuron Pharmaceuticals, Inc. Reduction of infarct volume using citicoline
EP1274444B1 (en) * 2000-03-16 2013-05-15 THE McLEAN HOSPITAL CORPORATION Cdp-choline and uridine for the treatment of alcohol abuse
CA2517290A1 (en) * 2003-02-26 2004-09-10 Kyowa Hakko Kogyo Co., Ltd. Muscle-building agent and preventive or remedy for muscle weakening
WO2005122767A1 (en) * 2004-06-10 2005-12-29 Mclean Hospital Corporation Pyrimidines, such as uridine, in treatments for patients with bipolar disorder
EP1765364A4 (en) * 2004-06-10 2010-09-22 Mclean Hospital Corp PYRIMIDINES, SUCH AS Z: B: CYTIDINE, IN THE TREATMENT OF PATIENTS WITH BIPOLAR DISORDER
US7947661B2 (en) * 2004-08-11 2011-05-24 The Mclean Hospital Corporation Compounds for the treatment of marihuana dependence, withdrawal, and usage
US20100041621A1 (en) * 2008-08-15 2010-02-18 Perry Renshaw Methods and compositions for improving cognitive performance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3666748A (en) * 1967-12-18 1972-05-30 Takeda Chemical Industries Ltd Method for production of cytidine (or deoxycytidine)-5{40 -diphosphate choline and intermediates therefor
NL149812B (nl) * 1969-04-24 1976-06-15 Takeda Chemical Industries Ltd Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van kristallijn cytidine-5'-difosfaat-choline-monohydraat.
JPS4841555B1 (es) * 1969-08-04 1973-12-07
JPS4886869A (es) * 1972-02-23 1973-11-15

Also Published As

Publication number Publication date
FR2480603B1 (fr) 1985-07-12
ZA812600B (en) 1982-04-28
DE3115080C2 (de) 1986-10-16
IT8048454A0 (it) 1980-04-18
FR2480603A1 (fr) 1981-10-23
IN156105B (es) 1985-05-18
SE447449B (sv) 1986-11-17
DK173081A (da) 1981-10-19
SE8102456L (sv) 1981-10-19
CH652026A5 (it) 1985-10-31
GB2074445A (en) 1981-11-04
ATA172081A (de) 1984-04-15
AT376366B (de) 1984-11-12
US4386077A (en) 1983-05-31
DE3115080A1 (de) 1982-02-25
AU6994581A (en) 1981-10-22
GB2074445B (en) 1983-09-07
BE890796A (fr) 1982-02-15
AU544469B2 (en) 1985-05-30
ES502080A0 (es) 1982-09-01
ES8207184A1 (es) 1982-09-01
IT1207106B (it) 1989-05-17

Similar Documents

Publication Publication Date Title
NL8101899A (nl) Farmaceutisch preparaat voor orale toediening met daarin cytidinedifosfocholine.
US5929066A (en) Chromium/biotin treatment of Type II diabetes
EP0201275B1 (en) Pharmaceutical compositions for treating metastasis of cancerous tumors
JP2528115B2 (ja) イノシト−ルトリホスフエ−トを含有する医薬組成物
CN1114404C (zh) 用噻唑烷二酮和二甲双胍治疗糖尿病
JP3699124B2 (ja) タイプｉｉ糖尿病のピコリン酸クロム高用量治療
JP2002249427A (ja) インスリン抵抗性糖尿病のための食事用補添物
AU751431B2 (en) Chromium/biotin treatment of type II diabetes
EP0786993A1 (en) Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders
GB2103485A (en) Liposomes containing antimony anti-leishmanaisis drugs
EP0374096B1 (de) 2',3'-Dideoxypurinnucleosid/Purinnucleosid-Phosphorylase-Inhibitor Kombinationstherapie und Zusammensetzungen dafür
CN106617072A (zh) 一种植物甾醇复合降脂组方及其片剂制备方法
DE60032915T2 (de) Gallium komplexe von 3-hydroxy-4-pyronen zur behandlung von durch intrazelluläre prokaryoten, dns- und retro-viren verursachten infektionen
CN1329497A (zh) 对乙型肝炎病毒的联合治疗
CA2574006A1 (en) Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis
OA11655A (en) Use of organophosphorous compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide for plants.
WO2005084660A1 (ja) ミトコンドリア病予防と対策
US7122209B2 (en) Oral compositions for the treatment of non-diabetic obese mammals, including humans
EP0530220A1 (en) PHARMACEUTICAL COMPOSITION.
JP4348084B2 (ja) 抗癌薬
WO2023109825A1 (zh) 氧化银和/或其水合物在制备药物中的用途
EP0082667A1 (en) Pharmaceutical compositions
AU2002302012B2 (en) Chromim/biotin treatment of type II diabetes
JPS6337767B2 (es)
CN1731992A (zh) 用于治疗和预防高脂血症的hypoestoxides、其衍生物及激动剂

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed